Author:
Mojarrad Majid,Momeny Majid,Mansuri Fatemeh,Abdolazimi Yassan,Tabrizi Mina Hajifaraj,Ghaffari Seyed Hamidollah,Tavangar Seyed Mohammad,Modarressi Mohammad Hussein
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,Hematology,General Medicine
Reference53 articles.
1. Osborne CK, Zhao H, Fuqua SA. Selective estrogen receptor modulators: structure, function, and clinical use. J Clin Oncol. 2000;18:3172–86.
2. Katzenellenbogen BS, Montano MM, Ediger TR, Sun J, Ekena K, Lazennec G. Estrogen receptors: selective ligands, partners, and distinctive pharmacology. Recent Prog Horm Res. 2000;55:163–93.
3. Early Breast Cancer Trialist’ Collaborative Group (EBCTC). Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomized trials. Lancet. 2005;365:1687–17. doi: 10.1016/S0140-6736(05)66544-0 .
4. Shiau AK, Barstad D, Loria PM, Cheng L, Kushner PJ, Agard DA, Greene GL. The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen. Cell Cycle. 1998;95:927–37.
5. Funakoshi T, Yanai A, Shinoda K, Kawano MM, Mizukami Y. G protein-coupled receptor 30 is an estrogen receptor in the plasma membrane. Biochem Biophys Res Commun. 2006;346(3):904–10. doi: 10.1016/j.bbrc.2006.05.191 .
Cited by
17 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献